Home›Search›Medical Letter on Drugs and Therapeutics

Medical Letter on Drugs and Therapeutics

Medical Letter Inc. · United States · Est. 2023

ISSN1523-2859

SJR Q3✓ WOS SCIE✓ Scopus / SJR

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ WoS flagship (SCIE/SSCI/AHCI)78

✓ Corroboration (2 more)+12

Total90

Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

Publication speed: not measurable

publisher doesn’t disclose per-article submission dates — we never estimate

SJR Rank

Top 75% in field

Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3. Source: Clarivate Journal Citation Reports.

SJR Scorei

0.257

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

0.446

Total Worksi

445

Total Citationsi

290

2yr Mean Citednessi

0.46

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

The Medical Letter on Drugs and Therapeutics is a biweekly publication that provides evidence-based, peer-reviewed evaluations of new FDA-approved drugs and new information on previously approved drugs. Its scope includes drug therapy and pharmacology.

AI-compiled from public web sources · verify on publisher page →

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2023

Annual Volume~ 141 articles / year

StatusActive (last: 2026)

Total Publications445

Publisher OrgThe Medical Letter, Inc.

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Medical Letter Inc.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1523-2859

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

145

161

2023

141

105

2024

137

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Medicine (miscellaneous)Q3

PharmacologyQ3

Pharmacology (medical)Q3

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

PharmacologyPharmacology (medical)Medicine (miscellaneous)

Research Topics (OpenAlex)

Diabetes Treatment and ManagementPharmaceutical studies and practicesLung Cancer Treatments and MutationsCAR-T cell therapy researchRespiratory viral infections researchSARS-CoV-2 and COVID-19 ResearchColorectal Cancer Treatments and StudiesAsthma and respiratory diseasesHER2/EGFR in Cancer ResearchPharmacology and Obesity Treatment

Frequently asked questions about Medical Letter on Drugs and Therapeutics

Is Medical Letter on Drugs and Therapeutics a predatory journal?

PubScope has no integrity flags on record for Medical Letter on Drugs and Therapeutics: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 90/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Medical Letter on Drugs and Therapeutics?

Medical Letter on Drugs and Therapeutics is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 0.46.

Is Medical Letter on Drugs and Therapeutics indexed in Scopus and Web of Science?

Medical Letter on Drugs and Therapeutics is indexed in Web of Science, Scopus.